In8bio Inc Stock Price To Earnings To Growth
| INAB Stock | USD 0.21 0.01 4.55% |
In8bio Inc fundamentals help investors to digest information that contributes to In8bio's financial success or failures. It also enables traders to predict the movement of In8bio Stock. The fundamental analysis module provides a way to measure In8bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to In8bio stock.
In8bio |
In8bio Inc Company Price To Earnings To Growth Analysis
In8bio's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, In8bio Inc has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
In8bio Fundamentals
| Return On Equity | -1.54 | ||||
| Return On Asset | -0.68 | ||||
| Current Valuation | 10.89 M | ||||
| Shares Outstanding | 81.26 M | ||||
| Shares Owned By Insiders | 5.00 % | ||||
| Shares Owned By Institutions | 36.95 % | ||||
| Number Of Shares Shorted | 3.76 M | ||||
| Price To Book | 1.17 X | ||||
| EBITDA | (30.44 M) | ||||
| Net Income | (30.44 M) | ||||
| Cash And Equivalents | 25.74 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 5.03 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 9.08 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (24.15 M) | ||||
| Short Ratio | 0.67 X | ||||
| Earnings Per Share | (0.57) X | ||||
| Target Price | 3.59 | ||||
| Number Of Employees | 18 | ||||
| Beta | 0.025 | ||||
| Market Capitalization | 16.98 M | ||||
| Total Asset | 20.94 M | ||||
| Retained Earnings | (121.66 M) | ||||
| Working Capital | 9.49 M | ||||
| Net Asset | 20.94 M |
About In8bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze In8bio Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of In8bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of In8bio Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out In8bio Piotroski F Score and In8bio Altman Z Score analysis. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.